GO nanosheets inhibit the proliferation of hPDLCs by covering the membrane to block the EGFR-AKT signaling pathway
Source abstract
Abstract
Graphene-based materials show potential applications in dentistry due to their outstanding physicochemical properties. However, the use of graphene and its derivatives increases their exposure risk to periodontal cells. This study aimed to evaluate the cytotoxicity caused by graphene in periodontal cells and clarify the potential molecular mechanism. Through a series of experiments, we isolated human periodontal ligament cells (hPDLCs) and subsequently investigated the cytotoxic behaviors and related signaling pathway through which graphene oxide (GO) nanohseets injured hPDLCs. Our findings illustrated that the cytotoxicity of GO against hPDLCs was derived from the covering of GO nanosheets on the membrane surface, which blocked the phosphorylation of epidermal growth factor receptor on the membrane. It further inhibited the activation of the serine/threonine kinase signaling pathway that promoted the proliferation and cycle progression of cells. This study revealed the toxic behavior of GO nanosheets to oral cells and elucidated the potential molecular mechanism, thereby providing theoretical guidance for the safe application of graphene-based materials in dentistry.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Carbon and Quantum Dots Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Graphene: status and prospects10.1126/science.1158877 ↗
2. Graphene-based electronic sensors10.1039/c2sc20205k ↗
3. Graphene-based nanomaterials for energy storage10.1039/C0EE00295J ↗
4. Graphene and its sensor-based applications: a review10.1016/j.sna.2017.12.028 ↗
5. Graphene: the new two-dimensional nanomaterial10.1002/anie.200901678 ↗
6. Influence of graphene oxide additions on the microstructure and mechanical strength of cement10.1016/S1872-5805(15)60194-9 ↗
7. Graphene and its derivatives: understanding the main chemical and medicinal chemistry roles for biomedical applications
8. Graphene and graphene oxide as new nanocarriers for drug delivery applications10.1016/j.actbio.2013.08.016 ↗
9. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles10.1002/adma.201104964 ↗
10. Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease10.1038/s41565-018-0179-y ↗
11. Graphene and its derivatives: opportunities and challenges in dentistry10.1016/j.msec.2019.04.051 ↗
12. Graphene nanosheets to improve physico-mechanical properties of bioactive calcium silicate cements10.3390/ma10060606 ↗
13. Physicochemical properties of nanocomposite: hydroxyapatite in reduced graphene oxide10.1016/j.msec.2017.02.044 ↗
14. Research on graphene and its derivatives in oral disease treatment10.3390/ijms23094737 ↗
15. Synthesis and performance of experimental resin-based dental adhesives reinforced with functionalized graphene and hydroxyapatite fillers10.1016/j.matdes.2022.110985 ↗
16. Growth and accelerated differentiation of mesenchymal stem cells on graphene-oxide-coated titanate with dexamethasone on surface of titanium implants10.1016/j.dental.2017.03.001 ↗
17. Polydopamine-mediated graphene oxide and nanohydroxyapatite-incorporated conductive scaffold with an immunomodulatory ability accelerates periodontal bone regeneration in diabetes10.1016/j.bioactmat.2022.03.021 ↗
18. Effects of composite films of silk fibroin and graphene oxide on the proliferation, cell viability and mesenchymal phenotype of periodontal ligament stem cells10.1007/s10856-014-5293-2 ↗
19. Killing dental pathogens using antibacterial graphene oxide10.1021/acsami.5b01069 ↗
20. Mechanisms of the antimicrobial activities of graphene materials10.1021/jacs.5b11411 ↗
21. Improved in vitro and in vivo biocompatibility of graphene oxide through surface modification: poly (acrylic acid)-functionalization is superior to PEGylation10.1021/acsnano.6b00539 ↗
22. Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites10.1073/pnas.1222276110 ↗
23. Nonmonotonic relationship between the oxidation state of graphene-based materials and its cell membrane damage effects10.1021/acsami.2c03520 ↗
24. Surface oxidation of graphene oxide determines membrane damage, lipid peroxidation, and cytotoxicity in macrophages in a pulmonary toxicity model10.1021/acsnano.7b07737 ↗
25. Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide10.1016/j.biomaterials.2012.05.064 ↗
26. Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages10.1021/nn402330b ↗
27. Periodontal ligament cells under mechanical force regulate local immune homeostasis by modulating Th17/Treg cell differentiation10.1007/s00784-021-04346-0 ↗
28. Graphene oxide toxicity in W1118 flies10.1016/j.scitotenv.2021.150302 ↗
29. XPS and structural studies of high quality graphene oxide and reduced graphene oxide prepared by different chemical oxidation methods10.1016/j.ceramint.2019.04.165 ↗
30. Graphene oxide and reduced graphene oxide studied by the XRD, TEM and electron spectroscopy methods10.1016/j.elspec.2014.07.003 ↗
31. Silibinin attenuates experimental periodontitis by downregulation of inflammation and oxidative stress10.1155/2023/5617800 ↗
32. Silk-fibroin and graphene oxide composites promote human periodontal ligament stem cell spontaneous differentiation into osteo/cementoblast-like cells10.1089/scd.2016.0028 ↗
33. Particle size-dependent antibacterial activity and murine cell cytotoxicity induced by graphene oxide nanomaterials10.1155/2016/6709764 ↗
34. A review of mammalian toxicity of ZnO nanoparticles10.2147/NSA.S23932 ↗
35. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways10.1016/j.tiv.2012.08.021 ↗
36. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress10.1016/j.taap.2012.03.023 ↗
37. Photoluminescence and fluorescence quenching of graphene oxide: a review10.3390/nano12142444 ↗
38. Protein corona mitigates the cytotoxicity of graphene oxide by reducing its physical interaction with cell membrane10.1039/C5NR01839K ↗
39. In vitro toxicity evaluation of graphene oxide on A549 cells10.1016/j.toxlet.2010.11.016 ↗
40. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways10.1016/j.biomaterials.2011.09.091 ↗
41. Protein corona reduced graphene oxide cytotoxicity by inhibiting endocytosis10.1016/j.colcom.2021.100514 ↗
42. DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis10.1016/j.molcel.2010.02.037 ↗
43. Graphene-induced pore formation on cell membranes10.1038/srep42767 ↗
44. Pi3k-pkb/akt pathway10.1101/cshperspect.a011189 ↗
45. EGFR mutations and lung cancer10.1146/annurev-pathol-011110-130206 ↗
46. Characterization and evaluation of graphene oxide scaffold for periodontal wound healing of class II furcation defects in dog10.2147/IJN.S163206 ↗
47. Minocycline hydrochloride-loaded graphene oxide films on implant abutments for peri-implantitis treatment in beagle dogs10.1002/JPER.19-0285 ↗